DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Mar 27, 2026 · 3mo ago · Accession 0001308179-26-000174
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Mar 27, 2026
- Report date
- May 14, 2026
- Document
- lrare2026_def14a.htm
- Size
- 16.3 MB